Introduction
Sarcoidosis has been reported to show immunological abnormalities related to cellular immuneabnormalities such as Thelper lymphocytic dys-and/or hypo-function similar to autoimmunediseases (1, 2) . Not only progressive systemic sclerosis (PSS), but also Hashimoto's thyroiditis, idiopathic thrombocytopenia, rheumatoid arthritis , and other autoimmune disorders are reported to exist with sarcoidosis (3) (4) (5) (6) (7) (8) (9) . Here, we describe a patient with interstitial pneumonia associated with PSS. This was complicated with sarcoidosis 3 years after the diagnosis of PSS and treated successfully with corticosteroids without modifying the underlying abnormalities associated with PSS, including interstitial pneumonia. Although previous case reports concerning the coexistence ofPSS and sarcoidosis have discussed similar immunoreactions of the two diseases, the present case showed the possibility that these two diseases could have a different pathogenesis.
Case Report
A 46-year-old womanwas admitted to Hokkaido University Hospital in 1989 because of Raynaud's phenomenon, trophic finger changes, scars on fingertips, shoulder stiffness, and dysphagia.
She was diagnosed as having PSS because of histological proof of skin lesions, and as having interstitial pneumonia in association with PSS (PSS-IP) because of infiltrative shadows and honeycombformation in bilateral lower lung fields in chest roentgenograms and computed tomography (CT) scans, as well as histological alveolitis in transbronchial lung biopsy (TBLB). In November 1992, her occasional chest roentgenogram revealed bilateral diffuse infiltrative shadows with no respiratory symptomsand she was re-admitted for further investigation. She had smoked 10 cigarettes daily for 20
years. Chest auscultation revealed inspiratory fine crackles over the lower lungs bilaterally.
Her fingers were red and edematous, but she developed no eczema or nodules. The chest roentgenogramon re-admission showeddiffuse small nodular opacities in whole lungs, especially in upper and middle lung fields, and inflltrative shadows in bilateral lower lung fields. In a chest CT scan (Fig. 1 , top 2,963 mg/dl, respectively), and low immunoglobulin E (IgE) (2 IU/7) levels. The serum angiotensin-converting enzyme (ACE) level was normal (14.6 mg/dl), but it was higher than the level at the first admission (8.6 mg/dl), and the genotype was II, which is commonin Japanese and is associated with low serum ACElevels. As for autoimmune antibodies, anti-nuclear antibody gave a diffuse, homogeneous, and speckled staining pattern and anti-SS-A antibody was also positive, but anti-DNA, anti-SS-B, and anti-Scl-70 antibodies were all negative. Pulmonary functions revealed worsening of restrictive ventilatory abnormalities and carbon monoxide diffusing capacity as shown in Table 1 . Arterial blood gas analysis during room airbreathing showed: pH7.418; Po278 mmHg; Pco245.4 mmHg.
TBLBwas performed at the right upper and basal segments (S3 and S8) and microscopic examination (Fig. 2) showed epitheloid granulomas of several sizes within the alveolar septa and alveolar cavities. No foreign body depositions, necrosis, or caseations could be recognized. These pathological findings were different from specimens obtained in the first admission in the thickness of the alveolar septum with mononuclearcell infiltration and the destruction of normal alveolar structure. Noabnormalities were recognized in ocular examinations and there were no other abnormalities, except for PSS, including histological abnormalities in dermal examinations. The liver biopsy specimen revealed no granulomas. Amyocardial biopsy was not performed. Bronchoalveolar lavage (BAL) was performed from left S4, which was normal, and right S2, which reflected the abnormal opacities. There was an increase in total cell counts, lymphocyte ratio and CD4/8 in BALfluid (BALF) and these findings were consistent with pulmonary sarcoidosis (Table 1) . Her clinical course for respiratory functions and BALF findings is shown in Table 1 .
We diagnosed that the additional pulmonary abnormal shadows were due to pulmonary sarcoidosis. Wetreated her with corticosteroids (0.5 mg/kg tapered off in 12 months), and after this treatment, her additional pulmonary opacities were completely resolved (Fig. 1, bottom ). There were also improvements of pulmonary functions and BALF findings (Table 1) . However, her basilar interstitial pneumonia and systemic feature of PSS remained unchanged throughout this period.
Discussion
The association of autoimmunedisorders and sarcoidosis has been repeatedly reported. In 1946, Teilum (10) reported similarities between connective tissue disease and granulomatous disease, and after this report, several reports proposed relationships between these two diseases. In 1974, Bara et al ( 1 1) firstreported a case ofsarcoidosis coexisting with PSS, and Wiesenhutter and Sharma (12) reported three cases with PSS and one case with SLE,with a review of the literature, and Maekawaand Nogami (9) reported one case of PSS and sarcoidosis with esophageal adenocarcinoma. Somecase reports have discussed sarcoidosis coexisting with autoimmune diseases such as Hashimoto's thyroiditis, idiopathic thrombocytopenia, and rheumatoid arthritis (3) (4) (5) (6) (7) (8) . However, the coexistence of sarcoidosis and connective diseases seems to be rare. James and Williams (1) and Needleman et al (2) thought that both sarcoidosis and autoimmune disorders have similar PSS-IP and Pulmonary Sarcoidosis immunoregulatory defects such as T-helper lymphocytic dysand/or hypo-function, and Yagura et al ( 1 3) explained immunological similarities between sarcoidosis and collagen vascular diseases such as the same cytokine activities, which may lead to decreased serum IgE levels. Furthermore, Wiesenhutter and Sharma (12) explained that sarcoidosis is similarto PSS or SLE in the profile of humoral and cellular immuneabnormalities such as decreased T lymphocytes or activated B lymphocytes. Both PSS and sarcoidosis have decreased lymphocyte reactivity to mitogens in vitro (14) (15) (16) . There are also decreases in the numbers of peripheral lymphocytes and T-cells in both PSS and sarcoidosis. The decreased T-cells are mainly suppresser (CD8) T lymphocytes and CD4lymphocyte alveolitis has been observed in sarcoidosis. On the other hand, helper (CD4) T lymphocyte and CD8lymphocyte alveolitis is observed in PSS (17) (18) (19) . These facts suggest that it is not easy to find a unified explanation for the pathogenesis of sarcoidosis and PSS. This case was diagnosed as PSS and PSS-IP by means of the histological findings of dermal and lung biopsies, followed by sarcoidosis diagnosed through serological examinations and lung biopsy. Sarcoidosis improved on corticosteroid treatment, but PSS and PSS-IP remained unchanged in chest CT scans.
The possibility of coexistence of these two diseases should be discussed. The exact prevalence of PSS is unknown, but in Japanese is estimated to be 5.05 cases per 100,000 population when calculated from the data of Takehara et al (20) . The prevalence of sarcoidosis in Japanese is estimated to be 5.34 cases per 100,000 population by Hiraga (21) . Though the coexistence of these two diseases is considered to be very rare judging from the above data, at least seven cases have been reported. These results suggest the existence of a relationship between PSSand sarcoidosis.
Two questions arose in the present case. The first was whether the lung involvement and dermal involvement diagnosed at first admission mighthave been due to sarcoidosis. The second was whether the exacerbated pulmonary shadows diagnosed as pulmonary sarcoidosis could have been due to the exacerbation of PSS-IP. Dermal findings on first admission showed Raynaud's phenomenon, trophic fingers, scars on fingertips, and shoulder stiffness, and microscopic findings showed inner skin fibrosis and micro-capillaritis, findings that were in accord with PSS, not sarcoidosis. Pulmonary involvement on first admission showed infiltrative shadows and honeycomb formation in bilateral lower lung fields on chest CT scans and pathological findings revealed cell infiltration and thickened interstitium without any granulation, suggesting interstitial pneumonia. That diagnosis was supported by restrictive impairment in lung function tests and a gallium-67 lung scan showing no uptake in bilateral lower lungs. Furthermore, as the chest CT scan on second admission showed diffuse ground glass opacities and small nodular opacities throughout the upper lung fields and biopsied specimens showed various sizes of epitheloid granulomaswithin the alveolar septa and alveolar cavities, these findings were in accord with sarcoidosis. Elevated serum ACElevels and decreased IgE levels, BALF findings from right S2 of increased total cell counts, lymphocyte ratio and CD4/8ratio, as well as decreased total lung capacity and permeability suggested the possibility of active sarcoidosis. It is true that sarcoidosis shows interstitial pneumonia in its end stage, but the clinical course mayrule out sarcoidosis. At the time of second admission, PSS-IP was inactive because of the chest CT scan finding of mainly honeycomb formation in the lower lung fields and the gallium-67 lung scan finding of no uptake in bilateral basal lungs. If these two diseases have a similar or the same pathogenesis, PSS may be worsened concomitantly at the time of worsening of sarcoidosis, and the dermal findings and interstitial pneumonia may improve with the healing of pulmonary sarcoidosis after corticosteroid treatment. However, the clinical courses of these two diseases seemed to progress independently in the present case. This supports the concept that sarcoidosis and PSSmay have a different pathogenesis and that the association of these two diseases maybe a chance occurrence.
